Synthesis of a tritium labelled antihistaminic drug [3H]-N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethaneamine · HCl
✍ Scribed by J. T. Kovalainen; H. Morimoto; P. G. Williams; J. Vepsäläinen; A. Reijonen; J. Gynther
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 362 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A tritium labelled antihistamine, N,N‐diethyl‐2‐[4‐(phenylmethyl)phenoxy]‐ ethaneamine · HCl (DPPE, 4) was synthesized to investigate its binding characteristics to intracellular histamine receptors (H~IC~) and for further studies with specific ligands of H~IC~ to determine their potential effects on cell proliferation. A palladium catalyzed reduction of an activated carbonyl between the two phenyl groups of N,N‐diethyl‐2‐[4‐(benzoyl)phenoxy]‐ethaneamine · HCl (DBPE, 3) with 100% tritium gas was successful, where 55% øf the theoretical activity (specific activity 31.6 Ci/mmol) was obtained.
📜 SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v
## Abstract Sumitriptan (1), a non‐selective 5‐HT~1B/1D~ agonist is an effective therapeutic agent for the acute treatment of migraine, but it is contraindicated for use in patients with known heart disease. The first Selective Serotonin One F Receptor Agonist (SSOFRA), 5‐(4′‐fluorobenz‐amido)‐3‐(_